Cover Image
市場調查報告書

BCC Research的Tarceva預測:肺癌治療藥Tarceva的長期性預測模式

BCC Research Tarceva Forecast: Long Term Forecasting Model for Lung Cancer Drug Tarceva

出版商 BCC Research 商品編碼 304814
出版日期 內容資訊 英文 Excel file/database
訂單完成後即時交付
價格
Back to Top
BCC Research的Tarceva預測:肺癌治療藥Tarceva的長期性預測模式 BCC Research Tarceva Forecast: Long Term Forecasting Model for Lung Cancer Drug Tarceva
出版日期: 2014年05月31日 內容資訊: 英文 Excel file/database
簡介

本報告提供全球、主要地區、主要國家的Tarceva的患者數、市值、人口資料,及吸煙者資料等。

目錄

  • 摘要圖表
  • 整體市值、患者數:各地區
  • 美國的患者數
  • 歐洲的患者數
  • 日本的患者數
  • 中國的患者數
  • 亞洲的患者數
  • 非洲/大洋洲的患者數
  • 中東的患者數
  • 南北美洲的患者數
  • 美國的人口:各年齡像
  • 歐洲的人口:各國
  • 日本的人口
  • 中國的人口
  • 亞洲的人口:各國
  • 非洲/大洋洲的人口:各國
  • 中東的人口:各國
  • 南北美洲的人口:各國
  • 美國的吸煙者資料
  • 歐洲的吸煙者資料:各國
  • 日本的吸煙者資料
  • 中國的吸煙者資料
  • 亞洲的吸煙者資料
  • 非洲/大洋洲的吸煙者資料:各國
  • 中東的吸煙者資料:各國
  • 南北美洲的吸煙者資料:各國
  • 美國的肺癌資料
  • 全球肺癌資料:男女、各地區
  • 歐洲的吸煙者資料:各國
  • 美國的價格,Tarceva的年度成本
  • 歐洲的價格、FX比率,Tarceva的年度成本,貨幣換算比率
  • 日本的價格、FX比率,Tarceva的年度成本,貨幣換算比率
  • 中國的價格、FX比率,Tarceva的年度成本,貨幣換算比率
  • 亞洲的價格、FX比率,Tarceva的年度成本,貨幣換算比率
  • 非洲/大洋洲的價格、FX比率,Tarceva的年度成本,貨幣換算比率
  • 中東的價格、FX比率,Tarceva的年度成本,貨幣換算比率
  • 南北美洲的價格、FX比率,Tarceva的年度成本,貨幣換算比率
目錄
Product Code: FMO001A

With BCC Research's Tarceva® Forecast, you will have quantitative data about forecasted revenue for the pharmaceutical drug Tarceva® that will guide you in your strategic decision-making regarding future participation in this product sector.

The BCC Research Tarceva® Forecast is a quantitative forecast model in an easily accessible Microsoft® Excel® spreadsheet, segmented by specific parameters. It features:

  • Market demand forecasts for Tarceva® annually for the years 2010 to 2030 by volume (number of patients) and value (in U.S. dollars)
  • Segmentation of volume and value for these regions:
    • United States
    • Japan
    • Europe
    • Latin America
    • China
    • Asia
    • Middle East
    • Data transparency and sources disclosed for:
  • Patient volumes, with forecasts by causal factors including population by age range, smoker data, and prevalence, as well as for population estimates at the country level
  • Product pricing and currency valuation forecasts

Use the BCC Research Tarceva® Forecast to:

  • Examine forecasted market demand for Tarceva®: competitor assessment; market opportunity assessment
  • Identify new business and investment opportunities for products in the lung cancer segment
  • Validate other Tarceva® market-demand data to which you have access
  • Tarceva® is a once-daily, oral, non-chemotherapy prescription drug for the treatment of advanced or metastatic non-small cell lung cancer (NSCLC). Some clinical studies have shown superior patient outcomes from use of Tarceva® as a second-line treatment for NSCLC. Tarceva® begins to fall outside of patent protection in numerous countries starting in 2020.
  • Tarceva is a registered trademark of OSI Pharmaceuticals. Microsoft and Excel are registered trademarks of Microsoft Corporation.

Table of Contents

  • Figure 1: Summary Graphs - Value in U.S.D. and Patient Volumes, by Region, 2010-2030
  • Table 1: Total Market - Value in U.S.D. and Patient Volumes, by Region, 2010-2030
  • Table 2: United States Patient Volumes, 2010-2030
  • Table 3: Europe Patient Volumes, 2010-2030
  • Table 4: Japan Patient Volumes, 2010-2030
  • Table 5: China Patient Volumes, 2010-2030
  • Table 6: Asia Patient Volumes, 2010-2030
  • Table 7: Africa/Oceania Patient Volumes, 2010-2030
  • Table 8: Middle East Patient Volumes, 2010-2030
  • Table 9: Americas Patient Volumes, 2010-2030
  • Table 10: United States Population by age range, 2010-2030
  • Table 11: Europe Population by Country, 2010-2030
  • Table 12: Japan Population, 2010-2030
  • Table 13: China Population, 2010-2030
  • Table 14: Asia Population by Country, 2010-2030
  • Table 15: Africa/Oceania Population by Country, 2010-2030
  • Table 16: Middle East Population by Country, 2010-2030
  • Table 17: Americas Population by Country, 2010-2030
  • Table 18: United States Smoker Data
  • Table 19: Europe Smoker Data by Country
  • Table 20: Japan Smoker Data
  • Table 21: China Smoker Data
  • Table 22: Asia Smoker Data by Country
  • Table 23: Africa/Oceania Smoker Data by Country
  • Table 24: Middle East Smoker Data by Country
  • Table 25: Americas Smoker Data by Country
  • Table 26: United States Lung Cancer Data, 1975-2010
  • Table 27: Global Lung Cancer Data, by Male and Female, by Region
  • Table 28: United States Pricing, Tarceva Annual Cost
  • Table 29: Europe Pricing and FX Rate, Tarceva Annual Cost, Currency Conversion Rates 2011-2014
  • Table 30: Japan Pricing and FX Rate, Tarceva Annual Cost, Currency Conversion Rates 2011-2014
  • Table 31: China Pricing and FX Rate, Tarceva Annual Cost, Currency Conversion Rates 2011-2014
  • Table 32: Asia Pricing and FX Rate, Tarceva Annual Cost, Currency Conversion Rates 2011-2014
  • Table 33: Africa/Oceania Pricing and FX Rate, Tarceva Annual Cost, Currency Conversion Rates 2011-2014
  • Table 34: Middle East Pricing and FX Rate, Tarceva Annual Cost, Currency Conversion Rates 2011-2014
  • Table 35: Americas Pricing and FX Rate, Tarceva Annual Cost, Currency Conversion Rates 2011-2014
Back to Top